Healthcare Select Sector SPDR (XLV) 67.39 $XLV Stocks

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Healthcare Select Sector SPDR (XLV) 67.39 $XLV

Stocks Stall on Eve of Fed's Rate Announcement
at The Street - Tue Mar 15, 3:08PM CDT
Investors were trigger-shy again on Tuesday, opting to wait on the sidelines ahead of a Federal Reserve announcement Wednesday afternoon.
VRX: 31.09 (-2.34), RDS.A: 48.28 (+0.58), GILD: 91.32 (+1.24), TOT: 45.28 (-0.25), PFE: 30.08 (-0.11), LLY: 71.12 (-0.05), BP: 30.42 (+0.22), CVX: 94.85 (+1.26), XLV: 67.39 (-0.03), CELG: 100.54 (+0.62), XLE: 61.84 (+0.30)

Stocks Slide as Energy, Health Care Slump
at The Street - Tue Mar 15, 1:56PM CDT
Stocks remain in the red Tuesday as crude oil trades at its lowest level in more than a week.
AVP: 4.28 (-0.10), VRX: 31.09 (-2.34), DDD: 14.76 (+0.32), PFE: 30.08 (-0.11), HDS: 32.06 (+0.25), LLY: 71.12 (-0.05), XLV: 67.39 (-0.03), CELG: 100.54 (+0.62), DRI: 65.77 (-0.75), RDS.A: 48.28 (+0.58), TOT: 45.28 (-0.25), GILD: 91.32 (+1.24), BP: 30.42 (+0.22), CVX: 94.85 (+1.26), XLE: 61.84 (+0.30)

AbbVie's Triangle Chart Formation Is Pointed South
at The Street - Thu Mar 10, 8:57AM CST
A breakdown below $52 should be the tipping point for further declines in ABBV. 
ABBV: 56.12 (-0.24), XLV: 67.39 (-0.03)

U.S. Sector PMI: 3 Sectors Post Lower Output In February
Markit - Seeking Alpha - Thu Mar 10, 3:17AM CST
US Sector PMI data from Markit provided further evidence of weakening US economic performance in February. Markit's manufacturing and services PMIs collectively showed the economy grinding to a halt in February, as signalled by a composite Output...
XTL: 55.29 (+0.01), XLB: 44.55 (unch), XLP: 52.32 (-0.06), XLY: 77.55 (+0.10), XLK: 43.62 (+0.12), XLI: 55.12 (-0.16), XLU: 48.91 (+0.13), XLF: 22.31 (-0.14), XLV: 67.39 (-0.03), XLE: 61.84 (+0.30)

The Zacks Analyst Blog Highlights: SPDR S&P Health Care Services ETF, Health Care Select Sector SPDR Fund, First Trust Health Care AlphaDEX Fund, Vanguard Health Care ETF and iShares U.S. Healthcare ETF
Zacks Equity Research - Zacks Investment Research - Wed Mar 09, 8:30AM CST
The Zacks Analyst Blog Highlights: SPDR S&P Health Care Services ETF, Health Care Select Sector SPDR Fund, First Trust Health Care AlphaDEX Fund, Vanguard Health Care ETF and iShares U.S. Healthcare ETF
IYH: 139.29 (-0.15), XHS: 53.64 (-0.30), VHT: 122.03 (-0.13), FXH: 54.61 (-0.07), XLV: 67.39 (-0.03)

Isolate Yourself From the Health Care Select Sector
at The Street - Tue Mar 08, 2:57PM CST
The outperformance of the XLV is slipping. 
XLV: 67.39 (-0.03)

Trump Healthcare Reforms: Will ETFs Gain Health or Suffer?
Sweta Killa - Zacks Investment Research - Tue Mar 08, 10:15AM CST
Is the Republican front-runner Donald Trump's new health care plan a boon or bane for healthcare ETFs?
IHE: 135.58 (-0.01), IHF: 119.69 (-0.53), PPH: 57.22 (-0.23), IYH: 139.29 (-0.15), PJP: 59.39 (-0.16), XHS: 53.64 (-0.30), XPH: 39.39 (-0.19), VHT: 122.03 (-0.13), FXH: 54.61 (-0.07), XLV: 67.39 (-0.03)

J&J, Pfizer, Merck, UnitedHealth -- Buy Them, Not the Health Care ETF
at The Street - Sun Mar 06, 11:20AM CST
These brand-name stocks are outperforming the exchange-traded fund.
JNJ: 108.31 (-0.19), UNH: 128.59 (-1.20), MRK: 53.07 (-0.01), PFE: 30.08 (-0.11), XLV: 67.39 (-0.03)

Why Acadia Healthcare Company Inc. Dropped 10.4% in February
Brian Feroldi, The Motley Fool - Motley Fool - Sun Mar 06, 7:43AM CST
Image source: Unsplash via Pixabay. What: Investors in Acadia Healthcare , an owner an operator of inpatient psychiatric facilities and treatment centers, had a rough February as the company's stock shed more than 10% of its value during the...
ACHC: 53.56 (-0.36), XLV: 67.39 (-0.03)

Last Month's Best Healthcare ETF
Brian Feroldi, The Motley Fool - Motley Fool - Sat Mar 05, 7:00AM CST
Source: Unsplash via Pixabay. February proved to be another roller-coaster month for investors. The  S&P 500  cratered in the first few trading days of the month, shedding more than 5.5% of its value at its lowest point, but then it came...
AGN: 279.32 (-1.99), GILD: 91.32 (+1.24), XLV: 67.39 (-0.03)

5 Revenant Sectors Echo Leo's Oscar-Winning Performance
Zacks Equity Research - Zacks Investment Research - Fri Mar 04, 2:30PM CST
Like the determined Hugh Glass, these sectors stood up to escape a bear market following massive sell-offs at the start of the year and register solid gains over the past month.
AMZN: 582.95 (+13.32), UNH: 128.59 (-1.20), XLY: 77.55 (+0.10), DIS: 97.22 (+0.39), IBB: 255.48 (+1.22), XOM: 83.98 (+0.23), XLV: 67.39 (-0.03), JPM: 59.48 (-0.46), MRK: 53.07 (-0.01), DD: 63.95 (+0.20), XLFS: 28.29 (-0.56), BRK.B: 140.11 (-0.85), CVX: 94.85 (+1.26), DOW: 51.32 (+0.14)

Trump, Clinton Race Ahead: ETFs in Contest
Sweta Killa - Zacks Investment Research - Fri Mar 04, 9:57AM CST
Trump and Clinton have their individual policies and goals in place for the betterment of the economy that are likely to influence the global stock markets and the ETF world.
IHF: 119.69 (-0.53), XLP: 52.32 (-0.06), VDC: 133.36 (-0.06), QCLN: 14.56 (+0.08), XOP: 29.78 (+0.37), FCG: 4.03 (+0.03), ITA: 116.32 (-0.97), IYR: 75.43 (+0.06), WIL: 52.03 (+0.36), TAN: 22.34 (-0.25), PPA: 34.96 (-0.18), VNQ: 80.95 (+0.03), XLV: 67.39 (-0.03)

Earnings: A Miracle? Or A Mirage?
Miles Hoffman - at Seeking Alpha - Fri Feb 19, 5:39PM CST

XTL: 55.29 (+0.01), XLB: 44.55 (unch), XLP: 52.32 (-0.06), XLY: 77.55 (+0.10), OIL: 5.30 (-0.06), XLK: 43.62 (+0.12), MCD: 123.29 (-0.90), XLI: 55.12 (-0.16), XLU: 48.91 (+0.13), XLF: 22.31 (-0.14), XLE: 61.84 (+0.30), XLV: 67.39 (-0.03)

It's Time To Buy Stocks
Markos Kaminis - at Seeking Alpha - Fri Feb 19, 2:22PM CST

USO: 10.06 (-0.05), XLB: 44.55 (unch), VXX: 19.30 (-0.11), XLU: 48.91 (+0.13), XLV: 67.39 (-0.03), VTI: 103.32 (-0.03), XLP: 52.32 (-0.06), SPY: 203.12 (-0.09), QQQ: 107.26 (+0.03), GLD: 116.33 (-0.28), DIA: 174.94 (+0.13), XLK: 43.62 (+0.12), IWM: 107.20 (+0.32), XLI: 55.12 (-0.16), XLF: 22.31 (-0.14), XLE: 61.84 (+0.30)

Dow Falls Into Red After Disney Wipes Out Gains
at The Street - Wed Feb 10, 1:52PM CST
Stocks are mixed as a dovish Federal Reserve boosts the S&P 500 and Nasdaq, while disappointing earnings from Disney help turn the Dow Jones Industrial Average lower.
FIT: 14.58 (+0.03), AMZN: 582.95 (+13.32), MDT: 73.97 (-0.53), FB: 113.05 (+0.51), DIS: 97.22 (+0.39), DB: 17.54 (-0.46), XLV: 67.39 (-0.03), TWX: 70.01 (-0.68), GILD: 91.32 (+1.24), AZN: 28.00 (-0.01), XLK: 43.62 (+0.12), MSFT: 54.21 (+0.24), CRM: 72.44 (+0.66), APC: 46.27 (-0.02)

Fasten Your Seatbelts: More Craziness in the Week Ahead
at The Street - Sun Feb 07, 6:12PM CST
The New Hampshire slugfest, China's week-long break for 'The Year of the Monkey,' Janet Yellen's grilling before Congress ... buckle-up for another bumpy ride in the week ahead.
ACHC: 53.56 (-0.36), TSLA: 227.75 (+5.17), KKR: 13.90 (-0.30), MOH: 63.34 (+0.42), TWX: 70.01 (-0.68), HUM: 184.07 (+0.48), PEP: 100.68 (-0.13), PBS: 23.83 (+0.03), ON: 9.39 (+0.01), ATVI: 32.21 (-0.37), AMSC: 7.45 (+0.01), FOXA: 27.75 (-0.04), XLK: 43.62 (+0.12), QLYS: 25.11 (+0.28), TWTR: 15.91 (-0.10), CSCO: 27.96 (+0.13), MLM: 153.67 (-0.17), KO: 45.58 (+0.12), RAI: 49.70 (-0.58), EZCH: 25.49 (+0.04), ITT: 36.67 (-0.07), MT: 4.26 (+0.09), XLV: 67.39 (-0.03), LPNT: 65.60 (-0.99), CVS: 101.43 (+0.69), TEVA: 54.29 (+0.24), CTSH: 60.32 (+1.26), VIAB: 39.68 (-0.02)

Can Boston Scientific Maintain Its Growth Momentum?
at The Street - Mon Feb 01, 6:15AM CST
Investors would be better served to focus on the value the company is working to create and less on the near-term macro headwinds
BSX: 17.93 (-0.23), VHT: 122.03 (-0.13), XLV: 67.39 (-0.03)

Will Obamacare Fail in 2016? Here are 3 Stocks Set to Benefit if it Does
Cheryl Swanson, Sean Williams, and Todd Campbell, The Motley Fool - Motley Fool - Sat Jan 30, 6:41AM CST
Courtesy of Flickr, Creative Commons No matter what you think of Affordable Care Act, there's no denying that healthcare has been a high-flying sector since the law took effect. No major index of large cap stocks has packed more punch  since...
MDT: 73.97 (-0.53), UNH: 128.59 (-1.20), AON: 101.13 (+0.62), XLV: 67.39 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BTQ Technologies Calls Investors for Key Quantum Update

Updated Category News Views 177

You know what's stirring the pot over at BTQ Technologies? A shareholder call coming up soon, and boy, it's got 'eye-opening insights' written all over it. We're talkin' Q3 financial results and, likely, a smattering of future plans on the quantum front, folks. Diving into BTQ's Quantum Vision BTQ Technologies Corp. (NASDAQ: BTQ) isn't just another tech firm banging on...

Continue Reading
Luvme Hair Offers Wig Variety for Winter Fashion

Updated Category News Views 194

Adding Flair to Winter Looks A style kick-off from the fashion world: Luvme Hair is flipping the table on winter wardrobes with a new collection of wigs. As the weather ramps up the need for thick coats and cumbersome layers, these long hairstyles offer a little extra swing, bringing dimension into the mix. Fancy a change from traditional winter hibernation? Here’s what...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 137

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
Ecopetrol Sidesteps Hefty Fines After Investigation Closure

Updated Category News Views 145

Colombian Watchdog Gives Ecopetrol a Pass It's like dodging a bullet in a duel at high noon. The Superintendency of Industry and Commerce (SIC) has finally closed its investigation into Ecopetrol S.A. and its subsidiaries, CENIT and OCENSA, after a probe two years in the making. The stakes were sky-high, folks. We're talkin' about just shy of 530 billion Colombian pesos...

Continue Reading
Microsoft's Cloud Misstep: Recovery Plans in Focus

Updated Category News Views 133

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

Continue Reading
El Pollo Loco Faces Class Action Over Wage Practices

Updated Category News Views 193

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Continue Reading
Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 197

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
Windward Bio Surges 68% in Nasdaq Debut

Updated Category News Views 134

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 138

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
HiTHIUM Joins Cambridge to Boost Global Energy Storage

Updated Category News Views 255

HiTHIUM and Cambridge's New Energy Venture There's a big splash coming out of Xiamen, folks. HiTHIUM, a heavyweight in the energy storage sector, has decided to team up with the University of Cambridge. They inked a deal aiming to bridge the academic ivory tower with industrial grit, focusing on long-duration energy storage. It was all sealed during the Global Energy...

Continue Reading

Top 5 Most Recently Viewed Articles

Kimbell Royalty Partners Engages Investors at Key Conferences

Updated Category News Views 101

Kimbell Royalty Partners to Attend Notable Investor Conferences Kimbell Royalty Partners, LP (NYSE: KRP) is a prominent owner of oil and natural gas mineral and royalty interests. The company proudly manages over 129,000 gross wells across multiple states. In an effort to strengthen investor relations and share its strategic outlook, Kimbell has announced its...

Continue Reading
Karsan's Autonomous Bus Debuts at Efteling Park

Updated Category News Views 72

A Leap Towards Autonomous Mobility What we have here is Karsan breaking new ground again. They've rolled out their Autonomous e-ATAK at Efteling, the famous theme park in the Netherlands. And that's not just any park—it's a place teeming with tourists, a hotspot demanding efficient transport. Yet, these folks aren't just cranking out fancy gadgets for showing off....

Continue Reading
EyePoint Pharmaceuticals Expands Workforce with Stock Options

Updated Category News Views 301

EyePoint Pharmaceuticals Expands Workforce with Stock Options EyePoint Pharmaceuticals, Inc. (Nasdaq: EYPT), a dynamic biopharmaceutical company, is on a mission to enhance the lives of patients facing serious retinal diseases. Recently, the company made a notable announcement regarding the expansion of its team through the granting of non-statutory stock options to new...

Continue Reading
IonQ Shares: Insights Into Their Current Market Performance

Updated Category News Views 204

Overview of IonQ's Current Stock Performance IonQ Inc. IONQ shares have seen a notable decline recently, continuing a downward trend that’s persisted over the last couple of weeks. As the company gears up to announce its second-quarter earnings, investors are closely monitoring the developments, particularly the anticipated shift in stock momentum. Market Sentiment and...

Continue Reading
Exploring the Promising CD47 Inhibitor Drug Market Growth

Updated Category News Views 40

Understanding the CD47 Inhibitor Drug Market Gaining insights into the CD47 inhibitor drug market is crucial for recognizing the changes and advancements in cancer immunotherapy. These drugs play a vital role in the battle against cancer by harnessing the body's immune system to identify and eliminate malignant cells. CD47's Role in Cancer CD47, often referred to as the...

Continue Reading